Latest news
How (RCKT) Movements Inform Risk Allocation Models - Stock Traders DailyStock Traders Daily · Fri, 07 Aug 2026 11:40:01 GMTRCKT Stock Dives Despite Gene Therapy Approval — Wall Street Dismisses Sell-Off - StocktwitsStocktwits · Fri, 07 Aug 2026 07:28:04 GMTRocket Pharmaceuticals, Inc. (RCKT) Class Action Lawsuit: Levi - The National Law ReviewThe National Law Review · Fri, 07 Aug 2026 05:12:39 GMTRCKT:ASX Announcement - Units on Issue Disclosure - July 2026 - 06 Aug 2026 - Market IndexMarket Index · Fri, 07 Aug 2026 00:41:30 GMTRocket Pharmaceuticals Inc (RCKT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Thu, 06 Aug 2026 07:00:00 GMTMorgan Stanley Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating, Maintains Target Price $5 - MoomooMoomoo · Tue, 04 Aug 2026 15:33:00 GMTRocket Pharmaceuticals Touts Positive Early Safety Data from Revised Genetic Therapy Trial - BenzingaBenzinga · Mon, 03 Aug 2026 16:03:07 GMTRocket Pharmaceuticals (RCKT) Reports Positive Safety Signals in Phase 2 Trial for Danon Disease - GuruFocusGuruFocus · Mon, 03 Aug 2026 13:01:56 GMT